BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10469040)

  • 1. Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5'-monophosphate-induced bronchoconstriction in patients with COPD.
    Rutgers SR; Koëter GH; Van Der Mark TW; Postma DS
    Clin Exp Allergy; 1999 Sep; 29(9):1287-92. PubMed ID: 10469040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma.
    Polosa R; Phillips GD; Rajakulasingam K; Holgate ST
    J Allergy Clin Immunol; 1991 May; 87(5):939-47. PubMed ID: 1673977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
    Rutgers SR; Koëter GH; van der Mark TW; Postma DS
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma.
    Phillips GD; Rafferty P; Beasley R; Holgate ST
    Thorax; 1987 Dec; 42(12):939-45. PubMed ID: 2894080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma.
    Crimi N; Palermo F; Oliveri R; Polosa R; Settinieri I; Mistretta A
    Eur Respir J; 1992 May; 5(5):560-5. PubMed ID: 1535321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma.
    Phillips GD; Holgate ST
    Am Rev Respir Dis; 1989 Feb; 139(2):463-9. PubMed ID: 2563320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of 4 weeks of oral H1 antagonist on bronchial responsiveness.
    Ruffin RE; Latimer KM
    Eur Respir J; 1991 May; 4(5):575-9. PubMed ID: 1682159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
    Spicuzza L; Scuderi V; Morjaria JB; Prosperini G; Arcidiacono G; Caruso M; Folisi C; Di Maria GU; Polosa R
    Pulm Pharmacol Ther; 2014 Feb; 27(1):70-5. PubMed ID: 23688422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled lysine acetylsalicylate (L-ASA) attenuates the bronchoconstrictor response to adenosine 5'-monophosphate (AMP) in asthmatic subjects.
    Crimi N; Polosa R; Magrì S; Prosperini G; Milazzo VL; Santonocito G; Mistretta A
    Eur Respir J; 1995 Jun; 8(6):905-12. PubMed ID: 7589376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cessation of short-term therapy with ipratropium bromide on lung function and airway responsiveness.
    Wilding PJ; Clark MM; Pavord ID; Parker D; Bennett JA; Tattersfield AE
    Eur Respir J; 1996 Aug; 9(8):1627-31. PubMed ID: 8866584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U46619-induced bronchoconstriction in asthmatic subjects is mediated by acetylcholine release.
    Saroea HG; Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):321-4. PubMed ID: 7842185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma.
    Phillips GD; Polosa R; Holgate ST
    Clin Exp Allergy; 1989 Jul; 19(4):405-9. PubMed ID: 2569356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of terfenadine and ipratropium bromide on ultrasonically nebulized distilled water-induced asthma.
    Azevedo M; da Costa JT; Fontes P; da Silva JP; Araujo O
    J Int Med Res; 1990; 18(1):37-49. PubMed ID: 2139858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of changes in adenosine 5'-monophosphate airway responsiveness with inhaled heparin in allergic asthma.
    Polosa R; Màgri S; Vancheri C; Armato F; Santonocito G; Mistretta A; Crimi N
    J Allergy Clin Immunol; 1997 Mar; 99(3):338-44. PubMed ID: 9058689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral terfenadine on bronchoconstrictor response to inhaled neurokinin A and histamine in asthmatic subjects.
    Crimi N; Oliveri R; Polosa R; Pulvirenti G; Prosperini G; Palemo F; Mistretta A
    Eur Respir J; 1993 Nov; 6(10):1462-7. PubMed ID: 8112439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma.
    Rafferty P; Beasley R; Holgate ST
    Am Rev Respir Dis; 1987 Aug; 136(2):369-73. PubMed ID: 3619195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilating effect of combined therapy with ipratropium bromide and ondansetron in patients with COPD.
    Pauwels R; Joos GF; Fogarty C; Faiferman I; Hirschberg S; Vessey R; Wouters EF
    Pulm Pharmacol Ther; 2008; 21(2):385-92. PubMed ID: 18023600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.